Episode 1: Florian Ederer on Killer Acquisitions

Florian Ederer discusses Killer Acquisitions, in which incumbent firms acquire small innovative firms with the express purpose of terminating the development of potential competitors. In the pharmaceutical industry, new drugs are developed at lower rates when their labs are acquired by large pharmaceutical companies which have similar drugs on the market.